2 hours ago
OpenAI Unveils GPT-Rosalind: New AI Model Targeting Pharmaceutical Research Acceleration
OpenAI's GPT-Rosalind AI model aims to accelerate drug discovery timelines, partnering with Amgen, Moderna, and Thermo Fisher for early-stage research.
The post OpenAI Unveils GPT-Rosalind: New AI Model Targeting Pharmaceutical Research Acceleration appeared first on Blockonomi.
Source: Blockonomi →Related News
- 36 minutes ago
AST SpaceMobile (ASTS) Stock Surges 5% Following Jim Cramer’s ‘Let’s Own This On...
- 43 minutes ago
State Street (STT) Stock Surges 4.56% on Stellar Q1 Performance and ETF Strength
- 44 minutes ago
Caterpillar (CAT) Stock Soars to Record $798.56 as Wall Street Eyes $905 Price T...
- 45 minutes ago
TSMC (TSM) vs ASML Stock: Analyzing the Superior AI Chip Investment for Long-Ter...
- 46 minutes ago
Michael Burry Reveals Major PayPal (PYPL) Position Amid Software Stock Buying Sp...